Compare LEE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEE | LNSR |
|---|---|---|
| Founded | 1890 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.1M | 146.7M |
| IPO Year | 2025 | 2005 |
| Metric | LEE | LNSR |
|---|---|---|
| Price | $8.86 | $12.05 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 76.0K | 40.1K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $543,955,000.00 | $53,494,000.00 |
| Revenue This Year | $5.48 | $19.55 |
| Revenue Next Year | N/A | $35.89 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.87 |
| 52 Week Low | $3.34 | $9.46 |
| 52 Week High | $11.21 | $17.31 |
| Indicator | LEE | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 70.07 | 51.24 |
| Support Level | $3.87 | $11.85 |
| Resistance Level | $9.50 | $12.80 |
| Average True Range (ATR) | 0.98 | 0.40 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 72.43 | 65.51 |
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.